Literature DB >> 22045160

Diagnosis: Intestinal inflammation--key to complications in cirrhosis?

Ravi K Prakash, Kevin D Mullen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22045160     DOI： 10.1038/nrgastro.2011.209

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Management of adult patients with ascites due to cirrhosis: an update.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

2.  Is poor quality of life always present with minimal hepatic encephalopathy?

Authors:  Ravi K Prakash; Kevin D Mullen
Journal:  Liver Int       Date:  2011-04-11       Impact factor: 5.828

3.  Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy.

Authors:  Ankur Gupta; Radha K Dhiman; Savita Kumari; Satyavati Rana; Ritesh Agarwal; Ajay Duseja; Yogesh Chawla
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

4.  Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

Authors:  Valle García-Sánchez; Eva Iglesias-Flores; Raúl González; Javier P Gisbert; José María Gallardo-Valverde; Angel González-Galilea; Antonio Naranjo-Rodríguez; Juan F de Dios-Vega; Jordi Muntané; Federico Gómez-Camacho
Journal:  J Crohns Colitis       Date:  2009-12-02       Impact factor: 9.071

5.  Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis.

Authors:  C Homann; P Garred; N Graudal; P Hasselqvist; M Christiansen; M K Fagerhol; A C Thomsen
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

6.  Rifaximin for the treatment of hepatic encephalopathy.

Authors:  Kevin Mullen; Ravi Prakash
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-12       Impact factor: 3.869

Review 7.  Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.

Authors:  J S Bajaj; J Cordoba; K D Mullen; P Amodio; D L Shawcross; R F Butterworth; M Y Morgan
Journal:  Aliment Pharmacol Ther       Date:  2011-02-09       Impact factor: 8.171

8.  Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis.

Authors:  Felix Gundling; Fabian Schmidtler; Alexander Hapfelmeier; Benjamin Schulte; Thomas Schmidt; Christian Pehl; Wolfgang Schepp; Holger Seidl
Journal:  Liver Int       Date:  2011-10       Impact factor: 5.828

Review 9.  Calprotectin - a pleiotropic molecule in acute and chronic inflammation.

Authors:  I Stríz; I Trebichavský
Journal:  Physiol Res       Date:  2004       Impact factor: 1.881

10.  A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues.

Authors:  G Zwadlo; R Schlegel; C Sorg
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.